[Drug-induced pseudolymphoma with predominantly cutaneous manifestation].
Sigal
M
M
Service de Dermatologie, Centre Hospitalier Victor Dupouy, Argenteuil.
Pulik
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects; D005260:Female; D005602:France; D006801:Humans; D008223:Lymphoma / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects; D011358:Product Surveillance, Postmarketing; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000175:diagnosis
D000927:Anticonvulsants; D002220:Carbamazepine; D010672:Phenytoin
Pseudo-lymphomes médicamenteux à expression cutanée prédominante.